<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00802750</url>
  </required_header>
  <id_info>
    <org_study_id>YA-LSM-0001</org_study_id>
    <nct_id>NCT00802750</nct_id>
  </id_info>
  <brief_title>Study Where Healthy Volunteers Evaluate LoFric Catheters</brief_title>
  <official_title>A Randomized, Single-blind, Cross-over, Single Centre Study in Healthy Volunteers Evaluating Subject Perception of Urinary Catheters Manufactured in a New Process With New Solvent</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wellspect HealthCare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wellspect HealthCare</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate healthy volunteers perception of catheterization&#xD;
      with LoFric catheters with new solvents in the manufacturing process. The subjects will be&#xD;
      catheterized three times during one visit day.&#xD;
&#xD;
      The hypothesis is that the subjects' perception of catheterization is the same when using the&#xD;
      test catheters compared to the reference catheter.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2008</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Healthy volunteers perception of catheterization</measure>
    <time_frame>At each catheterization (three times during one day)</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Catheterization</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LoFric POBE</intervention_name>
    <description>LoFric POBE, Nelaton 40 cm, CH 12 with new solvent. Each subject will use the reference catheter &quot;LoFric POBE, Nelaton 40 cm, CH 12 with current solvent&quot; before being catheterized with the test catheters.</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LoFric POBE</intervention_name>
    <description>Unsalted LoFric POBE Hydro-Kit II, Nelaton 40 cm, CH 12 with new solvent Each subject will use the reference catheter &quot;LoFric POBE, Nelaton 40 cm, CH 12 with current solvent&quot; before being catheterized with the test catheters.</description>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Provision of written informed consent&#xD;
&#xD;
          -  Healthy volunteers&#xD;
&#xD;
          -  Males age 18 years and over&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known or suspected, current impairment of and/or decreased urethral sensibility&#xD;
&#xD;
          -  History of urethral disease&#xD;
&#xD;
          -  History of urinary tract infection within three months, or ongoing symptomatic urinary&#xD;
             tract infection&#xD;
&#xD;
          -  Use of medications that may affect the urethra's dryness (e. g. anti-cholinergic drugs&#xD;
             or cortisone)&#xD;
&#xD;
          -  Current drug, alcohol or other substance abuse&#xD;
&#xD;
          -  Other significant disease or condition (e.g. benign prostate hypertrophy, other&#xD;
             prostatic lesions), which may interfere with treatment and/or evaluation&#xD;
&#xD;
          -  Allergy to Trimethoprim&#xD;
&#xD;
          -  Suspected poor compliance with the protocol during the complete study period.&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ulf Malmqvist, MD, PhD, Assoc.Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Research and Trial Centre, Lund University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinical Research and Trial Centre, Lund University Hospital</name>
      <address>
        <city>Lund</city>
        <zip>SE-221 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>December 4, 2008</study_first_submitted>
  <study_first_submitted_qc>December 4, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 5, 2008</study_first_posted>
  <last_update_submitted>February 4, 2021</last_update_submitted>
  <last_update_submitted_qc>February 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <pending_results>
    <submitted>April 20, 2021</submitted>
    <returned>May 13, 2021</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

